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Abstract
Retinitis Pigmentosa is a common form of hereditary retinal degeneration constituting the largest Mendelian genetic cause
of blindness in the developed world. It has been widely suggested that oxidative stress possibly contributes to its
pathogenesis. We measured the levels of total antioxidant capacity, free nitrotyrosine, thiobarbituric acid reactive
substances (TBARS) formation, extracellular superoxide dismutase (SOD3) activity, protein, metabolites of the nitric oxide/
cyclic GMP pathway, heme oxygenase-I and inducible nitric oxide synthase expression in aqueous humor or/and peripheral
blood from fifty-six patients with retinitis pigmentosa and sixty subjects without systemic or ocular oxidative stress-related
disease. Multivariate analysis of covariance revealed that retinitis pigmentosa alters ocular antioxidant defence machinery
and the redox status in blood. Patients with retinitis pigmentosa present low total antioxidant capacity including reduced
SOD3 activity and protein concentration in aqueous humor. Patients also show reduced SOD3 activity, increased TBARS
formation and upregulation of the nitric oxide/cyclic GMP pathway in peripheral blood. Together these findings confirmed
the hypothesis that patients with retinitis pigmentosa present reduced ocular antioxidant status. Moreover, these patients
show changes in some oxidative-nitrosative markers in the peripheral blood. Further studies are needed to clarify the
relationship between these peripheral markers and retinitis pigmentosa.
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Introduction
Retinal degenerations are the major cause of incurable
blindness characterized by loss of retinal photoreceptor cells.
Retinitis Pigmentosa (RP) is a common form of retinal degener-
ation, constituting the largest Mendelian genetic cause of blindness
in the developed world. It has a prevalence of 1 in 4000, and it has
been estimated that about two million people are affected
worldwide. Patients with RP typically loose night vision in
adolescence, peripheral vision in young adulthood, and central
vision later in life due to the progressive loss of rod and cone
photoreceptor cells by apoptosis [1]. About 20% of patients have
an associated hearing loss and the combination is called Usher
syndrome. There are approximately 60 genes implicated in the
pathology of RP [2,3].
Photoreceptor cell death starts with rod photoreceptor degen-
eration and eventually cone cell death, which is the major problem
affecting RP patients because it leads to loss of central vision. Cone
cells die possibly as a consequence of progressive oxidative damage
[4–8], metabolic dysregulation, loss of trophic support [9] and,
toxicity due to rod cell death [10]. Photoreceptor cells are
especially susceptible to oxidative stress because of their high
metabolic rate and their environmental risks such as exposition to
ultraviolet radiation or high oxygen tension. The endogenous
antioxidant machinery, which includes the mitochondrial antiox-
idant enzymes superoxide dismutases (SOD), glutathione perox-
idases and catalases [11], contributes to reduce oxidative stress in
photoreceptor cells. Rods represent 95% of all photoreceptors in
humans [12] and are the main consumers of oxygen in the outer
retina. Rods die in early stages of the disease, leading to an
overload of oxygen in the retina. The cone redox balance is then
disturbed and the resulting oxidative stress exceeds the antioxidant
capacity of cones, contributing to their death. The oxidative stress
hypothesis is supported by several lines of evidence in experimental
models of RP [6,7,13,14]. In these models, oxidative markers such
as decreased reduced form of gluthatione, increased malondialde-
hyde, or nitric oxide [7,13,15] have been found. Supporting this
idea, antioxidant formulations have reduced cone cell death in
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models of RP [6,7,16,17]. In addition, overexpression of the
endogenous antioxidant enzymes, including SOD and glutathione
peroxidase, decreased oxidative damage and prolonged cone
survival in some RP mouse models [18,19].
In this study, we evaluated the presence of some markers of the
antioxidant-oxidant status in aqueous humor and peripheral blood
of RP patients and compared them with those found in healthy
controls. We measured total antioxidant capacity, extracellular
superoxide dismutase (SOD3) activity, nitric oxide formation and
protein concentration in aqueous humor. We also determined
total antioxidant capacity, SOD3 activity, SOD3 content, cyclic
GMP, nitrotyrosine, nitric oxide and TBARS formation in
peripheral blood. In addition, we evaluated the relationship
between visual function and ocular antioxidant status. To our
knowledge, this is the first time that ocular antioxidant status has
been evaluated in RP patients.
Materials and Methods
Participants in the Study
Fifty-six patients with typical forms of RP characterized by an
elevated final dark-adaptation threshold, retinal arteriolar nar-
rowing, and a reduced and delayed electroretinogram were
enrolled in the study. Thirty-seven patients donated aqueous
humor and blood and only nineteen patients donated blood.
Smoking and antioxidant consumption were taken into account in
the study. Sixty age-matched subjects with no confounding ocular
or systemic disease (blood donors) and thirteen patients suffering
from cataracts without any other ocular or systemic disease
(aqueous humor donors) served as controls. Since this was a
retrospective non-randomized, observational study it was difficult
to know whether there were a hidden non-measured variable (diet,
environmental, etc.) affecting our results. However, it is possible to
look for these hidden data mentioned above, using the Rosenbaum
Sensitivity test [20], that addresses the possibility of hidden bias in
observational studies. This analysis may answer the question ‘‘how
high an unmeasured covariate’s effect would have to be to alter the
conclusions of the study’’. The result of the Rosenbaum Sensitivity
test showed that the differences found among groups are highly
insensitive against hidden bias, and therefore that there are not
hidden variable affecting our results.
The characteristics of the patients enrolled in the study, all of
them Caucasian, are shown in Table 1. Written informed consent
was obtained before extraction of aqueous humor and peripheral
blood. The procedure complied with the Declaration of Helsinki
and was reviewed and approved by the Ethics Committee of La Fe
University Hospital (Valencia, Spain).
Patients diagnosed with RP were recruited from Retina
Comunidad Valenciana- Asociacio´n Afectados por Retinosis Pigmentaria
and also from the Ophthalmology Service of La Fe University
Hospital (Valencia, Spain). Healthy controls were recruited from
the Ophthalmology Service of La Fe University Hospital
(Valencia, Spain) and also from the Biobank La Fe (Valencia,
Spain).
Ophthalmic Examination
Patients from which aqueous humor was obtained underwent a
full ophthalmic examination including best-corrected visual acuity
(BCVA) and automated visual field (VF). The BCVA was
measured according to the Early Treatment Diabetic Retinopathy
Study (ETDRS) protocol adapted for use in the Age-Related Eye
Disease Study [21]. We used the measurement of static perimetric
sensitivities (i.e., total point score) (30-2 program with size V
target; Humphrey Field Analyzer (HFA); Carl Zeiss Ophthalmic
Systems, Inc., Dublin, CA). The size V target was used to
minimize the number of locations with floor effects (sensitivity, #0
dB). The FASTPAC test strategy was used to test the central 30-2
visual field [22,23].
Aqueous Humor Extraction
Aqueous humor samples from 37 RP patients (31 with non-
syndromic RP and six with Usher syndrome) were collected under
sterile conditions in a cabin for controlled air quality (ARCSterile)
(ARCMedical, Barcelona, Spain). We applied one drop of
povidone iodine applied before and after the anterior chamber
was punctured using a 30-gauge needle. Antibiotic prophylaxis
was subsequently administered for several days. At the time of the
sample collection, six patients were smokers and 14 took some kind
of antioxidant supplements including vitamins, omega-3 fatty
acids, and minerals. Aqueous humor samples from 13 patients
suffering from cataracts without any other ocular or systemic
disease were collected with a 30-gauge needle just before the
beginning of the cataract surgery and served as controls. The
aqueous samples of controls were collected under the same
conditions before cataract surgery began. Undiluted aqueous
samples of at least 100 mL were collected from each patient,
placed in sterile tubes, and stored immediately at 280uC until use.
All specimens were assayed to evaluate antioxidant status in a
double-blind arrangement with respect to their group. For each
patient, aqueous humors were collected from the eye with the
more severe retinopathy or alternatively from the eye with the
worse visual acuity.
Serum Preparation
Whole blood (8 mL) without EDTA from 56 RP patients (41
with non-syndromic RP and 15 with Usher syndrome) and 60
healthy controls was obtained and centrifuged at 2000 g for five
min at 20uC. At the time of the sample collection, 10 patients were
smoker and 24 took some type of antioxidant supplements. Serum
was collected, aliquoted and frozen at 280uC prior to biochemical
determinations were performed. To avoid cGMP degradation
7 mM EDTA was added to an aliquot before freezing.
Evaluation of Antioxidant-oxidant Status
Antioxidant-oxidant status was analysed in aqueous humor and
serum from RP patients and healthy controls. Serum samples were
assayed for total antioxidant capacity (TAC), TBARS formation as
Table 1. Characteristics of participants included in the study.
Aqueous humor samples Blood samples
Control RP Control RP
Nu of subjects 13 37 60 56
Males 7 26 31 26
Females 6 11 29 30
Age (yr) 6063 4662 4162 4462
Type of RP – 3 AR – 5 AR
7 AD 8 AD
6 USH 15 USH
21 unknown 28 unknown
Note: RP: non syndromic RP; USH: Usher syndrome; AR, autosomic recessive;
AD, autosomic dominant.
doi:10.1371/journal.pone.0074223.t001
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indicator of malonyldialdehyde (MDA) formation, and SOD3
activity.
TAC was measured using a commercial kit (Cayman Chemical,
Ann Arbor, MI) according to manufacturer’s instructions. Serum
and aqueous humor TAC levels were expressed as mmol/mL.
MDA levels were detected by a colorimetric method involving
thiobarbituric acid (TBA) adduct formation (Cayman Chemical,
Ann Arbor, MI) according to manufacturer’s instructions. Serum
TBARS levels were expressed as mmol/L.
SOD3 activity was measured using a commercial kit (Cayman
Chemical, Ann Arbor, MI) according to manufacturer’s instruc-
tions. Serum and aqueous humor SOD3 activity were expressed as
U/mL.
Western Blot
Fifty mg total serum protein from 28 RP patients and 27 healthy
controls were subjected to electrophoresis in a 10% polyacryl-
amide gel containing 0.1% SDS under reducing conditions,
transferred to a polyvinylidene difluoride (PVDF) membrane, and
probed with rabbit anti-human SOD3 (1:3000, abcam plc,
Cambridge, UK) or rabbit anti-human transferrin (1:1000, abcam
plc. Cambridge, UK). The images were captured using an
EPSON SCAN from EPSON Corporation (EPSON IBERICA,
Barcelona, Spain) and quantified using the Alpha Imager 2200
(version 3.1.2) software (AlphaInnotech Corporation, San Fran-
cisco, CA, USA). SOD3 content was normalized to transferrin, a
loading control for serum samples [24].
Cyclic GMP Determination
Serum preserved in 7 mM EDTA was used to determine the
amount of cGMP. cGMP was measured by using the BIOTRAK
cGMP enzyme immunoassay kit (GE Healthcare Europe GmbH,
Barcelona, Spain). cGMP levels were expressed as pmol/mL.
Nitrites and Nitrates (NOX) Determination
Nitrites (stable end-product of NO) and nitrates (NOX) levels
were measured in serum by the spectrophotometric Griess
reaction [25] using nitrate reductase. Serum NOX levels were
expressed as nmol/mL.
Nitrotyrosine Determination
Serum-free nitrotyrosine was measured by the analytical
method LC-MS/MS system, which consisted of an Acquity
Ultraperformance LCH liquid chromatography system coupled to
an AcquityH TQ-S triple quadruple mass Spectrometer (Waters,
Manchester, UK).
Nitrotyrosine and phenyl-alanine-D5 (internal standard) stock
solutions were separately prepared at 200 mM in deionized water.
Two internal standard solutions at 2 mM and 0.1 mM, and a
nitrotyrosine solution at 10 mM were prepared separately in
deionized water from the respective stock solutions. Subsequent
work solutions were prepared by dilution 1:1 (v/v) with deionized
water of the nitrotyrosine solution (10 mM) within the concentra-
tion range from 625 nM to 0.153 nM. After thawing at room
temperature, 50 mL of serum was precipitated (1:2, v/v) with ice-
cold acetonitrile (ACN), vortexed, and centrifuged at 13000 g for
15 min at 4uC. Then, 100 mL of the supernatant was evaporated
to dryness using a Savant Speed Vac SPD121P concentrator
(Thermo Fisher Scientific SLU, Madrid, Spain) and redissolved in
100 mL of deionized water containing the internal standard
(0.1 mM). Finally, the solution was injected into the LC-MS/MS
system. Mobile phase consisted of deionized water and ACN, both
containing 0.1% (v/v) of formic acid (FA). The injection volume
was 5 mL.
The triple quadrupole MS detector operated in positive
electrospray ionization (ESI) mode by selected reaction monitoring
(SRM). Calibration curves were obtained by plotting the target
analyte/internal standard peak area ratio for each analyte against
its added concentration. Free nitrotyrosine levels were expressed as
nmol/L.
Protein Concentration
Protein concentration was measured in aqueous humor and
serum by the bicinchoninic acid (BCA) protein assay (BCA Kit;
Pierce Scientific, CA). Protein content was expressed as mg/mL.
Human Mononuclear Cell Isolation
Whole blood (4 mL) with EDTA from 20 RP patients and 20
healthy controls was obtained and diluted with one volume of
phosphate-buffered saline (PBS). Peripheral blood mononuclear
cells (PBMC) were obtained as described by Kimura et al. [26]. In
brief, diluted blood was layered onto Lymphoprep solution
(density 1.077 g/mL, AXIS-SHIELD, Oslo, Norway) and centri-
fuged at 800 g for 20 min at 20uC. The pellet containing
mononuclear cells was collected and washed with three volumes
of phosphate-buffered saline and centrifuged at 450 g for 10 min.
The cellular pellet was frozen at 280uC until RNA extraction.
RNA Extraction and cDNA Synthesis
Total RNA was isolated from PBMC using RNeasy mini kit
(Qiagen, Hilden, Germany) following the manufacturer’s protocol.
RNA concentration and purity were determined by UV spectro-
photometry at 260 and 280 nm wavelengths. Then, cDNA was
synthesized from 1 mg of total RNA by reverse transcription using
the GeneAmp Gold RNA PCR Reagent kit (Applied Biosystems,
Carlsbad, CA, USA) following manufacturer’s instructions.
Quantitative Real-time PCR Analysis in PBMC
The relative expression of inducible nitric oxide synthase (iNOS)
(Hs01075529_m1) and heme oxygenase 1 (HO-1)
(Hs01110250_m1) was evaluated by qPCR using the TaqManH
gene expression assay (Applied Biosystems, Life Technologies
Corporation, Carlsbad, California, USA). Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) (Hs02758991_g1) gene was
used as a housekeeping gene control. A positive control of iNOS
was obtained from human umbilical vein endothelial cells
(HUVEC) treated with 10 mg/mL LPS for 4 hours.
Statistical Analyses
All statistical analyses were done using R software (version
2.15.3) (Foundation for statistical computing, Vienna, Austria).
Multivariate analysis of covariance (MANCOVA) [27], fuzzy
clustering [28,29], Mann-Whitney test, Rosenbaum’s Sensitivity
test [20] and multiple linear regression models were used to
analyze the data. A 0.05 significance threshold was used.
Results
Antioxidant Status in Eyes from Patients with Retinitis
Pigmentosa
Fifty aqueous humor samples were collected from 37 RP
patients (31 with non-syndromic RP and six with Usher syndrome)
and from 13 healthy controls. Table 1 shows demographic features
of all participants enrolled in this study. Few markers could be
explored because of limited availability of aqueous humor
Antioxidant Status in Retinitis Pigmentosa
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including TAC, SOD3 activity, NOX formation and protein
concentration. Descriptive statistics of each marker are shown in
Table 2.
Since several markers (response variables) were measured from
the same individuals and since these variables were correlated,
performing analysis of covariance (ANCOVA) tests for each
response variable would yield non- independent results and make
the results difficult to interpret. This approach would also increase
the family-wise type I error rate. A sensible approach would be to
assess group differences on all the response variables considered
simultaneously. Following this approach, we performed a multi-
variate analysis of covariance (MANCOVA) with the disease, age,
gender, and antioxidant consumption as predictive variables. This
revealed that RP significantly altered ocular antioxidant status in
aqueous humor (p = 0.001) (Table 3). We found no statistical
evidence for gender, age or antioxidant consumption effects.
Further analysis of each of the response variables indicated that
TAC and SOD3 activity were decreased in patients with RP
(p = 0.017 and p,0.001, respectively). Stable end-products of
nitric oxide, NOX, were not affected by RP (p = 0.630). However,
protein concentration showed a tendency to decrease in RP
patients (p = 0.057). No statistical differences (p = 0.450) were
found between patients with syndromic RP (Usher syndrome) and
non-syndromic RP (data not shown).
Due to the large number of oxidants contained in cigarette
smoke, we analyzed whether smokers (16% of patients) showed an
altered antioxidant status compared to non-smokers in aqueous
humor. No statistical differences were found between smoker and
non-smoker patients (p = 0.490).
Antioxidant-oxidant Status in the Peripheral Blood of
Patients with Retinitis Pigmentosa
In light of these results, we assessed whether antioxidant-oxidant
status was also disturbed in peripheral blood. Blood samples were
collected from 41 patients with non-syndromic RP, 15 patients
with syndromic RP (Usher syndrome) and 60 healthy controls
(Table 1). We analyzed the following markers: TAC, SOD3
activity and content, TBARS formation (as an indicator of lipid
peroxidation) and metabolites of the NO/cGMP pathway.
MANCOVA revealed alterations in the antioxidant-oxidant
status in serum of RP patients (p = 0.002) (Table 3). Descriptive
statistics of each response variable are shown in Table 4. This
analysis indicated that age seems to play a role in serum
antioxidant-oxidant status, with higher levels of oxidative-nitrosa-
tive markers in older participants than in younger participants
(p = 0.012). However, we did not find statistical evidence for
gender or antioxidant consumption effects. Our results revealed
that while serum SOD3 activity was decreased, serum TBARS
formation was significantly increased in RP patients (p = 0.025 and
p = 0.004 respectively) compared to healthy controls. No signifi-
cant differences were found in serum TAC.
No statistical differences were found between healthy controls
(0.3360.04 a.u) and RP patients (0.2360.03 a.u, Mann-Whitney
test, p = 0.21) in serum SOD3 content (Fig. 1A). We analysed
whether SOD3 content correlated with SOD3 activity in serum
samples (Fig. 1B). SOD3 activity almost correlated with SOD3
content in healthy subjects (Spearmans coefficient = 0.37, p = 0.06)
(Fig. 1C). However, no correlation was found for RP patients
(Spearmans coefficient =20.07, p = 0.74) (Fig. 1D).
The serum NO/cGMP pathway was also analyzed by
measuring NOX formation, free nitrotyrosine and cGMP levels
and expression of iNOS in PBMC. Serum NOX was significantly
higher in RP patients (p = 0.033) than in healthy controls. Free
nitrotyrosine, another indicator of NO formation in vivo, was not
included in MANCOVA due to the high number of missing values
in this variable. However, results clearly suggested that free
nitrotyrosine levels were higher in RP patients (2.660.2 nM,
n = 41) than in healthy controls (1.760.1 nM, n = 34) (Fig. 2). No
iNOS expression was detected by qPCR in PBMC of RP patients
or healthy controls. The content of cGMP, a downstream effector
of NO, was higher in RP patients than in healthy controls
(p = 0.015). Elevated serum cGMP could be a consequence of
higher soluble guanylate cyclase (sGC) activation by NO or carbon
monoxide (CO). CO is generated through heme oxygenase
enzymes HO-I and HO-II. qPCR analysis revealed that HO-I
Table 2. Antioxidant-oxidant markers and protein in aqueous
humor from RP patients and healthy controls.
Control RP
TAC (mmol/mL) 1.4660.1 1.0660.1*
SOD3 (U/mL) 9.861.5 3.760.4**
Protein (mg/mL) 3.660.2 3.160.2
NOX (nmol/mL) 198625 231622
Note: RP: retinitis pigmentosa; TAC: total antioxidant capacity; SOD: superoxide
dismutase; NOX: nitrates and nitrites. Values are expressed as mean 6 SEM.
MANCOVA was carried out considering all response variables (TAC, SOD3,
Protein and NOX) simultaneously (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0074223.t002
Table 3. MANCOVA in aqueous humor and blood from
patients with RP and healthy controls.
Aqueous humor Blood
Predictive
Variables
Pillais
trace P-value
Pillais
trace P-value
Age 0.1261 0.2753 0.1832 0.0119
Gender 0.1003 0.4043 0.1107 0.1307
Disease RP 0.3841 0.0010 0.2579 0.0025
Antioxidant
consumption
0.2014 0.0737 0.0752 0.3403
Note: Pillais trace, multivariate test criteria used in the MANCOVA.
doi:10.1371/journal.pone.0074223.t003
Table 4. Antioxidant-oxidant markers in blood from RP
patients and healthy controls.
Control RP
TAC (mmol/mL) 1.1560.04 1.1760.05
SOD3 (U/mL) 11.6060.70 8.3060.40*
TBARS (mmol/L) 5.1060.20 7.1060.40**
NOX (nmol/mL) 4962 5763*
cGMP (pmol/mL) 0.4160.03 0.6860.06*
Note: RP: retinitis pigmentosa; TAC: total antioxidant capacity; SOD: superoxide
dismutase; TBARS: thiobarbituric acid reactive substances; NOX: nitrates and
nitrites; cGMP: cyclic guanosine monophosphate. Values are expressed as mean
6 SEM. MANCOVA was carried out considering all response variables (TAC,
SOD3, TBARS, cGMP and NOX) simultaneously (*p,0.05, **p,0.01).
doi:10.1371/journal.pone.0074223.t004
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was up-regulated (Mann-Whitney test, p,0.05) in PBMC from
RP patients (Fig. 3).
Similar to what we found in the aqueous humor samples, there
were no statistical differences between patients with syndromic RP
(Usher syndrome) and non-syndromic RP (p = 0.710), and
between smoker and non-smoker patients (p = 0.550) in all studied
response variables (data not shown).
Taken together, these results allowed us to conclude that RP
patients present reduced ocular antioxidant status that could
contribute to the progression of the disease, especially to cone
death. Moreover, the RP patients show, unexpectedly, imbalances
in their peripheral blood antioxidant-oxidant homeostasis.
Ocular Antioxidant Status and Visual Function in Retinitis
Pigmentosa
In order to assess the possible relationship between ocular
antioxidant status and best-corrected visual acuity or visual field in
RP patients, we first assigned to each individual a value between 0
(lowest antioxidant status) and 1 (highest antioxidant status)
computed through fuzzy clustering classification according to
their NOX, SOD3, protein and TAC values (Fig. 4). The new
computed variable was used as a predictor of best-corrected visual
acuity and visual field in a multiple linear model including age, sex
and antioxidant consumption as covariates. This revealed a strong
association between the ocular antioxidant status and the visual
field (p = 0.009), and suggests that RP patients with better visual
field are more likely to belong to cluster 1 (highest antioxidant
status). However, no effect was found on best-corrected visual
acuity (p = 0.927). Analysis showed that 35% (multiple R-squared
(R2) = 0.352) of the variability in visual field was associated to
changes in the antioxidant status.
Discussion
The retina is highly susceptible to oxidative stress because of its
high oxygen consumption, its high content of polyunsaturated fatty
acids, and direct exposure to light. Increasing evidence suggests
that oxidative stress contributes to the pathogenesis of RP [6,7,18].
To our knowledge this is the first time that the level of ocular
antioxidant status in RP patients has been analyzed. We
determined the levels of different markers of the antioxidant-
oxidant status in aqueous humor and blood from RP patients, and
compared them with those in healthy controls to confirm an
alteration of this status.
Recently, it has been shown that the composition of the aqueous
humor is affected by the pathophysiology of RP [30] as occurs in
Figure 1. Protein content of SOD3 in serum from RP patients
and healthy controls. (A) Fifty mg of total serum protein were
subjected to electrophoresis and extracellular SOD3 content was
analysed by inmunoblotting, as described in Materials
The immunological signal of SOD3 was normalized to transferrin, a
loading control for serum samples; Correlation analysis between SOD3
activity and SOD3 content in serum from patients and healthy controls
(B), healthy controls (C) or patients (D). Spearman’s correlation test was
used (rs = correlation coefficient).
doi:10.1371/journal.pone.0074223.g001
Figure 2. Blood free nitrotyrosine concentration in RP patients
and healthy controls. Free nitrotyrosine was measured by LC-MS/MS
system as described in Materia and Methods.
mean 6 SEM.
doi:10.1371/journal.pone.0074223.g002
Figure 3. Gene expression of heme oxygenase I in peripheral
blood mononuclear cells of RP patients and healthy controls.
mRNA expression was quantified by qPCR analysis as described in
Materials and Methods. qPCR data were normalized
gene, GAPDH. C; healthy controls, RP: patients with retinitis pigmentosa;
PBMC: peripheral blood mononuclear cells. Mann-Whitney test was
used (*p,0.05).
doi:10.1371/journal.pone.0074223.g003
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and Methods.
ousekeeping  hto
ls Values are expressed as
other retinal diseases such as glaucoma [31], diabetic retinopathy
[32], or age-related macular degeneration [33]. We found that the
aqueous humor levels of TAC and SOD3 activity were lower in
RP patients than in healthy controls. TAC and SOD are
considered good biological markers of the endogenous antioxidant
defence system. Therefore our results suggest that the endogenous
antioxidant defence system is reduced in the eye of RP patients,
and hence they have less capacity to cope with toxic oxygen
intermediates.
The SODs are important antioxidant enzymes that catalyze the
dismutation of the free radical superoxide into oxygen and
hydrogen peroxide in many tissues, including the retina. The
human eye expresses three types of SOD: the extracellular
superoxide dismutase or SOD3, the cytosolic copper- and zinc-
containing SOD or SOD1 and, the mitochondrial manganese-
containing SOD or SOD2 [34]. SOD3 regulates extracellular
concentrations of reactive oxygen species (ROS) and reactive
nitrogen species (RNS) preventing the production of peroxynitrite,
and possibly contributes to tissue protection during inflammatory
insults [35,36]. Therefore the reduced activity of SOD3 detected
in the eye of RP patients could result in elevated superoxide [37],
and SOD3 down-regulation may contribute to the inflammatory
process recently described in RP [30,38].
Concerning the other two SOD enzymes, it has been shown
that retinal overexpression alone of SOD1 protected retinal cells
from a severe oxidative stress induced by hyperoxia [39] but had
deleterious effects in rd1 mice [18]. However, the authors showed
that combined overexpression of SOD1 or SOD2 with the
peroxide-metabolizing enzyme (glutathione peroxidase 4 or
catalase) within the same cellular compartment was able to reduce
cone cell death in RP models [18,19].
Numerous experimental and clinical studies indicate altered
ocular blood circulation, including retinal flow [40] and choroidal
circulation [40–43] in RP patients, possibly as a result of vascular
remodelling in response to reduced metabolic demand [40,44] and
low aqueous humor VEGF-A levels [45]. Reduced aqueous humor
protein concentration detected in patients could be, at least in
part, a consequence of this blood flow disturbance.
Interestingly, we found that oxidative-nitrosative stress markers
are high in blood from RP patients. During oxidative stress,
different ROS and RNS such as superoxide, hydrogen peroxide,
NO, and peroxynitrite are generated. Increased superoxide
radicals resulting from decreased SOD3 activity could, in
combination with high NO formation, lead to increase peroxyni-
trite formation in blood of RP patients. Peroxynitrite can induce
lipid and protein oxidation, and nitration of proteins [46].
Nitration is the most extensive post-translational modification of
proteins and can strongly affect their biological function [47].
High blood levels of nitrotyrosine could contribute to the nitration
of SOD3 impairing its activity [48] without affecting the total
protein content in RP patients. This could be a possible
explanation for the lack of correlation between SOD3 activity
and SOD3 content in RP patients. Furthermore, elevated levels of
nitrotyrosine in retina of rd1 mice correlated with cone cell death,
suggesting that NO exacerbates oxidative damage to cones in RP
[49].
NO is a diffusible gas synthesized from L-arginine via three
different isoforms of NOS (neuronal NOS, endothelial NOS and
Figure 4. Heatmap representation of the fuzzy clustering results for antioxidant-oxidant markers in aqueous humor of RP patients.
The dark red to dark blue colors correspond to high to low values. Individuals classified as with higher oxidant status show low TAC, protein and
SOD3 levels and medium to high NOX levels. Individuals classified as with lower oxidant status show low NOX levels and high SOD3, protein and TAC
levels.
doi:10.1371/journal.pone.0074223.g004
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inducible NOS). Our results demonstrated a strong tendency to
up-regulate NO, free nitrotyrosine, and its downstream effector,
cGMP, in the blood of RP patients. NO can act through the
stimulation of the sGC with subsequent formation of cGMP.
Interestingly, up-regulation of HO-I can also contribute to
increasing cGMP levels in RP patients. Up-regulating the HO
system should generate cytoprotective products such as bilirubin,
biliverdin, and carbon monoxide (CO) that in turns should
stimulate sGC [50]. On the other hand, HO induction may play
an important role in the antioxidant defense system in oxidative
stress-related diseases such as RP, age-related macular degener-
ation or in retinal damage situations such as intense light damage,
retinal detachment or ischemia-reperfusion injury [51–53].
In blood vessels, cGMP is involved in relaxation of vascular
smooth muscles leading to vasodilation and increased blood flow
and inhibition of adhesion and aggregation of platelets. Systemic
vascular impairment has been described in patients with RP [54].
Cellini et al [55] and Ohguro et al [56] reported that elevated levels
of plasma endothelin- 1 (ET-1) which is a potent vasoconstrictive
peptide found in RP patients, could lead to vasoconstriction of
cutaneous capillaries. However, the increase of ET-1 in blood of
RP patients is controversial [57]. The elevated cGMP can be
considered as an adaptive response to vasoconstriction, or may
simply be a consequence of the high NO levels associated with
oxidative stress.
We found that levels of blood lipid peroxidation (measured by
TBARS formation) were significantly elevated in RP patients
compared with those in healthy controls, supporting previous
findings [58,59]. Retinal photoreceptor outer segment membranes
are very sensitive to lipid peroxidation [60]. Lipid peroxidation
injures photoreceptor cell membranes resulting in cell damage in
different animal models of RP [7,61]. It is likely, thus, that the
retina of RP patients shows lipid peroxidation.
We found statistical evidence supporting an association between
visual field and ocular antioxidant status in RP patients. This
association seems to corroborate that an imbalance in the
antioxidant machinery system is involved in the pathogenesis of
RP, similar to other ocular diseases such as age-related macular
degeneration, retinopathy of prematurity, retinal light damage,
and glaucoma [29–31,62,63]. However, further studies are needed
to analyze how antioxidant-oxidant status progresses at different
stages of RP.
Under our experimental conditions, we found that patients with
antioxidant consumption, including vitamins and omega-3 fatty
acids, did not present higher antioxidant status than those without
antioxidant consumption. Instead, they showed a trend toward
diminishing TAC and SOD3 activity. However, we cannot
conclude that, in this case, antioxidant consumption really
worsened antioxidant status because our study was not designed
to test for this. Each patient took a different kind and dose of
nutritional supplement and we did not measure antioxidant status
before treatment. Antioxidant supplements may have differential
effects on oxidative stress responses, depending on the timing, dose
and duration of the antioxidant consumption. Therefore, the
effectiveness of antioxidant supplementation on antioxidant-
oxidant status needs to be explored in detail. At present, the use
of vitamin A and omega-3 fatty acids as appears to be an effective
treatment for patient with RP, although the interpretation of
clinical trials remains controversial [64–67]. Nonetheless several
antioxidant treatments in experimental models of RP suggest a
positive action of these treatments in slowing down or reducing the
progression of the disease [6,16,68].
Concerning the effect of smoking, we did not find statistical
evidence for a negative effect on the antioxidant-oxidant status in
RP patients. Unfortunately there was no data for the control group
but the proportion in the RP group (16% for aqueous samples and
18% for serum samples) was below average of smokers in Spanish
population (35%) [69]. Therefore, if we assume that our control
group represent the Spanish population this imbalance would raise
mean oxidative stress in control group compared to RP group,
maybe increasing type II error (false negative) but not type I error
(false positive).
In conclusion, we found that RP patients present a reduced
ocular antioxidant status, and an imbalance of the antioxidant-
oxidant status in the peripheral blood. Therefore the eyes of the
RP patients could have less capacity to cope with toxic oxygen
intermediates. Although RP is a genetic disease, this reduced
capacity could contribute to the progression of the degeneration,
especially to cone death [7].
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